Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Lodrini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Endocrinology|July 27, 2004
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin statusRenato Cozzi, Roberto Attanasio, Sandro Lodrini, et al.
Acta Neurochirurgica|February 1, 2012
Spinal cord herniation: management and outcome in a series of 12 consecutive patients and review of the literatureFrancesco Prada, Andrea Saladino, Sergio Giombini, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkageRenato Cozzi, Marcella Montini, Roberto Attanasio, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?Renato Cozzi, Roberto Attanasio, Marcella Montini, et al.
The Oncologist|September 28, 2011
DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrenceFrancesca Menghi, Francesca N Orzan, Marica Eoli, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Endocrinology|July 27, 2004
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin statusRenato Cozzi, Roberto Attanasio, Sandro Lodrini, et al.
Acta Neurochirurgica|February 1, 2012
Spinal cord herniation: management and outcome in a series of 12 consecutive patients and review of the literatureFrancesco Prada, Andrea Saladino, Sergio Giombini, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkageRenato Cozzi, Marcella Montini, Roberto Attanasio, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?Renato Cozzi, Roberto Attanasio, Marcella Montini, et al.
The Oncologist|September 28, 2011
DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrenceFrancesca Menghi, Francesca N Orzan, Marica Eoli, et al.
Pageof 1